SCHEMBL26418768

SCHEMBL26418768

Cc1cc2nc3cc(O)c(O)cc3nc2cc1CCc1cc2nc3cc(O)c(O)cc3nc2cc1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.48
MAPT P10636 2/20 0.48
NQO2 P16083 2/20 0.40
NPSR1 Q6W5P4 1/20 0.36
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
PGK1 P00558 1/20 0.33
RPS6KB2 Q9UBS0 1/20 0.32
ALDH1A1 P00352 2/20 0.31
PLAA Q9Y263 1/20 0.31
TYR P14679 1/20 0.31
ALPG P10696 1/20 0.31
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31
STAT3 P40763 1/20 0.31
MEN1 O00255 1/20 0.30
GAPDH P04406 1/20 0.30
THRB P10828 1/20 0.30
APEX1 P27695 1/20 0.30
RAD52 P43351 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2449714 0.82 KDM4E (0.68) KDM4EMAPTNQO2NPSR1NPC1
SCHEMBL15581107 0.80 KDM4E (0.58) KDM4EMAPTNQO2NPSR1NPC1
SCHEMBL9979780 0.74 MAPT (0.46) KDM4EMAPTNQO2NPSR1NPC1
SCHEMBL27437406 0.71 KDM4E (0.48) KDM4EMAPTNQO2NPC1RAB9A
SCHEMBL15581106 0.70 KDM4E (0.46) KDM4EMAPTNQO2NPSR1NPC1
SCHEMBL10784379 0.69 KDM4E (0.50) KDM4EMAPTNQO2NPSR1NPC1
SCHEMBL6206349 0.68 NQO2 (0.71) KDM4EMAPTNQO2NPSR1NPC1
SCHEMBL13388975 0.68 NQO2 (0.72) KDM4EMAPTNQO2NPC1RAB9A
SCHEMBL24950993 0.67 KDM4E (0.40) KDM4EMAPTNQO2
SCHEMBL5678026 0.67 HMGCR (0.45) KDM4EMAPTNPSR1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230125359-A1 COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230125359-A1 COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND RAD51, UBE2D3, MDM2 KDM4E 4361/4885MAPT 3319/4885NQO2 2966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.